Cytosorbents Corporation (CTSO)
NASDAQ · Healthcare
Cytosorbents Corporation annual/quarterly long term debt history from 2016 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Cytosorbents Corporation long term debt for the quarter ending December 31, 2025 were 16.7M, a 19.08% increase year-over-year.
- Cytosorbents Corporation long term debt for 2025 were 16.7M, a 19.08% increase from 2024.
- Cytosorbents Corporation long term debt for 2024 were 14.0M, a 177.54% increase from 2023.
- Cytosorbents Corporation long term debt for 2023 were 5.0M, a 0.86% increase from 2022.
- Cytosorbents Corporation long term debt for 2022 were 5.0M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Cytosorbents Corporation Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $17 |
| 2024 | $14 |
| 2023 | $5 |
| 2022 | $5 |
| 2019 | $15 |
| 2018 | $10 |
| 2017 | $10 |
| 2016 | $5 |
| Cytosorbents Corporation Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $17 |
| 2024-12-31 | $14 |
| 2023-12-31 | $5 |
| 2022-12-31 | $5 |
| 2019-12-31 | $15 |
| 2018-12-31 | $10 |
| 2017-12-31 | $10 |
| 2016-12-31 | $5 |
Cytosorbents Corporation Long Term Debt — FAQ
Cytosorbents Corporation (CTSO) long term debt over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTSO's long term debt history?
The chart and table above show Cytosorbents Corporation's long term debt by year and by quarter, including the growth rate.